Clinical Trials Directory

Trials / Completed

CompletedNCT07487142

Prevalence of Asymptomatic H Pylori Infection Among Patients Undergoing PCI and Impact of Its Eradication on Occurrence of GIT Symptoms and Bleeding"

"Prevalence of Asymptomatic Helicobacter Pylori Infection Among Patients Undergoing Percutaneous Coronary Intervention and Impact of Its Eradication on Occurrence of Gastrointestinal Symptoms and Bleeding"

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
121 (actual)
Sponsor
Beni-Suef University · Academic / Other
Sex
All
Age
35 Years – 70 Years
Healthy volunteers
Not accepted

Summary

In the present study, the aim was to report the prevalence of positive H. pylori infection in an unselected population referred for coronary intervention and likely to required DAPT or DPI, also the study assessed impact of H. pylori eradication on occurrence of GI symptoms or bleeding during the follow up period.

Conditions

Interventions

TypeNameDescription
DRUGBISMUTH TETRACYCLINE METRONIDAZOLE OMEPRAZOLEPCI patients h pylori positive

Timeline

Start date
2024-06-10
Primary completion
2025-12-24
Completion
2025-12-24
First posted
2026-03-23
Last updated
2026-03-23

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07487142. Inclusion in this directory is not an endorsement.

Prevalence of Asymptomatic H Pylori Infection Among Patients Undergoing PCI and Impact of Its Eradication on Occurrence (NCT07487142) · Clinical Trials Directory